Received Oct 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | AH7Z3 | — |
diluted the one vial presentation of Menveo with sterile water; diluted the one vial presentation of Menveo with sterile water and then the dose was given to a patient.; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 11-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number AH7Z3, expiry date 30-SEP-2026) for prophylaxis. On 26-SEP-2025, the patient received Menveo. On 26-SEP-2025, an unknown time after receiving Menveo, the patient experienced wrong solution used in drug reconstitution (Verbatim: diluted the one vial presentation of Menveo with sterile water) and inappropriate dose of vaccine administered (Verbatim: diluted the one vial presentation of Menveo with sterile water and then the dose was given to a patient.). The outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were not applicable. Additional Information: GSK receipt date:02-OCT-2025 A reporter diluted the one vial presentation of Menveo with sterile water and then the dose was given to a patient, The nurse was asked for recommendations about this situation. The reporter was consented to follow up.